Sigmanomics
Back to all insights

Breaking News: Humacyte Inc. Faces Lawsuit for Alleged Securities Law Violations – How You Can Protect Your Investment with the Schall Law Firm

Breaking News: Humacyte Inc. Faces Lawsuit for Alleged Securities Law Violations – How You Can Protect Your Investment with the Schall Law Firm

Overview

LOS ANGELES, CA / ACCESSWIRE / December 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humacyte, Inc. (“Humacyte” or “the Company”) (NASDAQ:HUMA) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between May

more insights

“Breaking News: Major World Chain Embraces Chainlink’s CCIP for Seamless Cross-Chain Operations!”

January 24, 2025

World Chain Adopts Chainlink’s Cross-Chain Interoperability Protocol (CCIP) World Chain has taken a significant step towards enhancing blockchain interconnectivity by integrating with Chainlink’s Cross-Chain Interoperability Protocol (CCIP). This collaboration marks a pivotal moment in the evolution of decentralized systems, allowing developers and users on World Chain to build secure, interoperable

Read more >
Sigmanomics

Menu

About

News

Signals

Risk Disclaimer: Sigmanomics is a financial portal that provides news and analysis about the different financial markets. The articles that we serve on the portal depend solely on the opinion and analysis of our economists which in no way are intended to incite a visitor of the website or an investor to trade or sell/buy a certain instrument. It is the responsibility of the visitor / trader only to evaluate his trading strategies and whether he is capable of trading with taking into consideration that losing all the capital invested is a possibility. The visitor should seek an independent professional financial advisor to discuss his or her trading strategies. Moreover, the provided rates for the different instruments are indicative only and cannot be used for trading purposes. Therefore, no responsibility can be imposed on sigmanomics.com.com and the company operating the portal for any loss of money that may occur to the visitor by using the website.